USPTO 2015–2025 USPTO PatentsView US Corporation

Medline Industries, Lp

USPTO PatentsView assignee record - 753 granted patents across 80 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

753
Total patents granted
80
CPC technology areas
10.3
Avg claims per patent
+18%
5-year filing velocity

The verdict

Medline holds 753 US patents across 80 technology areas, rank #592 of 50,000 tracked assignees.

#592
of 50,000 US assignees by volume
Top 4%
by Innovation Score (58.7/100)
10.3
avg claims per patent
+18%
filing velocity, last 5 yrs

Portfolio overview

Medline Industries, Lp has been granted 753 US utility patents between 2015 and 2025, placing Medline Industries, Lp at rank #592 across all assignees tracked by PlainPatent. This portfolio spans 80 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.3 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Medline Industries, Lp is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Medline sits between Mediatek Singapore Pte. Ltd. (761 patents, rank #588) and Steering Solutions IP Holding Corporation (747 patents, rank #596) - the closest US assignees by grant volume. The composite Innovation Score of 58.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 408 grants, compared with 345 in the 2015–2019 window, a +18% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medline Industries, Lp's 10.3 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a multi-domain presence across 80 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medline Industries, Lp against peers pursuing similar technology classes.

Who files at Medline's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medline holds 753 patents at rank #592, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medline

By rank, the assignees closest to #592 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medline's primary technology class.

Medline's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

20406080100120 20152016201720182019202020212022202320242025 41
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medline Industries, Lp patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 42 5.6%
2016 60 8.0%
2017 88 11.7%
2018 71 9.4%
2019 84 11.2%
2020 105 13.9%
2021 77 10.2%
2022 56 7.4%
2023 77 10.2%
2024 52 6.9%
2025 41 5.4%

Which technologies does Medline Industries, Lp patent most?

Top 15 of 80 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Simple
Velocity Growing

Where it ranks

Overall rank by patents

#592

Across all tracked assignees

Innovation Score

58.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medline Industries, Lp hold?
Medline Industries, Lp holds 753 US granted patents filed between 2015 and 2025, spanning 80 technology areas.
What is Medline Industries, Lp's Innovation Score?
Medline Industries, Lp has an Innovation Score of 58.7 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Medline Industries, Lp focus on?
Medline Industries, Lp's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 135 patents. The company has filed patents in 80 CPC subclasses total.
Is Medline Industries, Lp's patent filing rate increasing or decreasing?
Medline Industries, Lp's recent filing velocity is +18% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Medline Industries, Lp's patents?
Medline Industries, Lp's patents average 10.3 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Medline Industries, Lp patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medline's 753 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Medline ranks #592 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.